Skip to Content
Merck
CN
  • Transforming Endothelium with Platelet-Rich Plasma in Engineered Microvessels.

Transforming Endothelium with Platelet-Rich Plasma in Engineered Microvessels.

Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2019-12-25)
Ryan J Nagao, Raluca Marcu, Yuliang Wang, Lu Wang, Chris Arakawa, Cole DeForest, Junmei Chen, José A López, Ying Zheng
ABSTRACT

Vascularization remains an obstacle when engineering complex tissues for regeneration and disease modeling. Although progress has been made in recreating 3D vascular structures, challenges exist in generating a mature, functional endothelium. It is demonstrated that perfusing engineered microvessels with platelet-rich plasma, a critical homeostatic component in vivo that is often overlooked in vitro, substantially transforms the endothelium, both maturing endothelial cells and improving functionality in 24 h. Platelets readily adhered to the exposed collagen-I substrate through small gaps within engineered vessels without forming thrombi. The adherent platelets improve barrier function, enhance endothelial glycolysis, reduce thrombogenicity, and enrich smooth muscle cell growth surrounding the endothelium. These findings demonstrate that platelets are essential to the function of endothelium during vascular maturation and remodeling. This study sheds light on a potential strategy to engineer stable, implantable vascular networks.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Protamine sulfate, meets USP testing specifications
Sigma-Aldrich
Carbonyl cyanide 3-chlorophenylhydrazone, ≥97% (TLC), powder
Sigma-Aldrich
Tetramethylrhodamine methyl ester perchlorate, ≥95%